Dr. Rachel Kelly is an Assistant Professor of Medicine at the Channing Division of Network Medicine, Brigham and Women's Hospital, and an Associate Epidemiologist at Harvard Medical School. Since completing her PhD in molecular biomarkers of non-Hodgkin's at Imperial College London, her work has focused on the metabolomic epidemiology of complex diseases. Dr. Kelly's particular interests lie in the integration of metabolomic data with other omic datatypes to provide the most complete understanding of the pathogenesis of phenotypes ranging from asthma to neurodevelopmental disorders. Dr. Kelly also has extensive experience in teaching the fundamentals of metabolomics and metabolomic data analyses, and has developed a number of workshops and courses focused on omic technologies.